Latest Duchenne muscular dystrophy Stories
Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine.
HUNTINGTON’S DISEASE, for the FIRST time in history was treated in March 2012 by Dr.’s Feinerman and Paino in our state of the art clinic in Lima, Peru.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.